Aflibercept for neovascular age‐related macular degeneration
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Aflibercept for Neovascular Age‐related Macular Degeneration." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435165/all/Interventions_for_increasing_ankle_range_of_motion_in_patients_with_neuromuscular_disease_New. Accessed 19 March 2024.
Aflibercept for neovascular age‐related macular degeneration. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435165/all/Interventions_for_increasing_ankle_range_of_motion_in_patients_with_neuromuscular_disease_New. Accessed March 19, 2024.
Aflibercept for neovascular age‐related macular degeneration. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435165/all/Interventions_for_increasing_ankle_range_of_motion_in_patients_with_neuromuscular_disease_New
Aflibercept for Neovascular Age‐related Macular Degeneration [Internet]. In: Cochrane Abstracts. [cited 2024 March 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435165/all/Interventions_for_increasing_ankle_range_of_motion_in_patients_with_neuromuscular_disease_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aflibercept for neovascular age‐related macular degeneration
ID - 435165
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435165/all/Interventions_for_increasing_ankle_range_of_motion_in_patients_with_neuromuscular_disease_New
DB - Evidence Central
DP - Unbound Medicine
ER -